The Pharma Data

MAY 7, 2021

population in just a few months, the BLA submission is an important cornerstone of achieving long-term herd immunity and containing COVID-19 in the future,” said Ugur Sahin, M.D., The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. The information contained in this release is as of May 7, 2021.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

The Pharma Data

AUGUST 17, 2020

Bristol Myers Squibb intends to advance the research and development of DF6002 in oncology and hematology. “As Executive Vice President & President, Research & Early Development, Bristol Myers Squibb. About Bristol Myers Squibb. Bristol Myers Squibb Cautionary Statement Regarding Forward-Looking Statements.

Licensing 52

Licensing Licensing Development Production 52

Camargo

DECEMBER 13, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. The regulations regarding BLAs for therapeutic biological products are included in 21 CFR parts 600 , 601 , and 610.

Development 161

Development Production Immune Response Licensing 161

Pfizer

SEPTEMBER 27, 2022

Pfizer is focused on increasing treatment options for patients through research and development as well as innovative, technically advanced manufacturing practices. We’re proud to be strengthening our capacity to develop and produce more advanced medicines that can help improve the lives of patients. Medicines, Research.

Vaccination 45

Vaccination Vaccine Medicine Gene Therapy 45

The Pharma Data

OCTOBER 29, 2020

Tokyo, Japan) today announced that the European Medicines Agency (EMA) has confirmed it has accepted for review, following a standard timetable, the Marketing Authorization Application (MAA) for aducanumab, an investigational treatment for Alzheimer’s disease. CAMBRIDGE, Mass. and TOKYO, Oct. Since October 2017 Biogen and Eisai Co.,

Medicine 40

Medicine Marketing Clinical Trials Clinical Trials 40

The Pharma Data

NOVEMBER 30, 2020

1, 2020 /PRNewswire/ — Sosei Group Corporation (“the Company”) (TSE: 4565) announces it has entered into a global collaboration and license agreement with Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”, NYSE: BHVN). . TOKYO and CAMBRIDGE, England , Dec. Sosei Group Forward-looking statements.

Licensing 40

Licensing Licensing Production Development 40

The Pharma Data

DECEMBER 16, 2020

NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced it has entered into a collaboration and license agreement with Otsuka Pharmaceutical Co., All forward-looking information contained in this press release is qualified by this cautionary statement. VICTORIA, British Columbia & ROCKVILLE, Md.–(

Licensing 52

Licensing Licensing Development Sales 52

Pfizer

SEPTEMBER 27, 2022

Embodied by our “Science Will Win” campaign, Pfizer is at the forefront of the vital research being conducted to find treatments, cures and preventive medicines to the diseases that currently confound us. Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5-Adapted Medicines, Research.

Medicine 52

Medicine Vaccination Vaccine Licensing 52

Pharmaceutical Technology

MAY 15, 2023

Pyridine derivatives contain one nitrogen atom in a six-membered aromatic ring and are the most extensively used heterocycles in the field of drug design, due to their promising effect on pharmacological activity, which has led to the discovery of numerous broad-spectrum therapeutic agents.

Antibody 130

Antibody DNA Genome Genomics 130

The Pharma Data

APRIL 27, 2023

About GSK’s RSV older adult vaccine candidate GSK’s RSV older adult vaccine candidate contains a recombinant subunit RSV prefusion F glycoprotein antigen (RSVPreF3) combined with the Company’s proprietary AS01 E adjuvant. Additional regulatory submissions will continue throughout this year. These were typically mild to moderate and transient.

Vaccination 40

Vaccination Vaccine Trials Containment 40

The Pharma Data

OCTOBER 20, 2020

We look forward to successful commercialization and licensing of TLC’s programs across the globe under Mr. Bliss’s leadership, as well as to creating benefit and bringing value for all of TLC’s stakeholders.”. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

The Pharma Data

DECEMBER 17, 2020

NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. TARRYTOWN, N.Y. , 17, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc.

Antibody 52

Antibody Medicine Production Trials 52

The Pharma Data

DECEMBER 10, 2020

Food and Drug Administration and the European Medicines Agency. Senior Vice President and Head of Vaccine Research & Development, Pfizer. “As We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

Vaccination 52

Vaccination Vaccine Trials Medicine 52

The Pharma Data

MAY 4, 2021

Lilly is offering donations of baricitinib to the Indian government through Direct Relief while simultaneously working with local Indian pharmaceutical companies to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic. BA HCP ISI 09JUL2020.

Licensing 40

Licensing Licensing FDA Approval Development 40

Client Pharma

APRIL 3, 2020

Response : contain, control or minimize the impacts of any incident(s). Preparedness : take steps before an incident to ensure effective response and recovery. Recovery : take steps to minimize disruption and recovery times. Q: How are Client-Pharma’s warehousing and distribution channels being managed?

Licensing 52

Licensing Licensing Containment Clinical Research 52

XTalks

JANUARY 28, 2022

Immunocore received Breakthrough Device Designation for Kimmtrak from the FDA in February 2021 followed by acceptance of its Biologics License Application (BLA) several months later by both US and European regulators. Related: Cancer Blood Test Developed by University of Oxford Researchers Can Detect Metastasis.

FDA Approval 98

FDA Approval Development Licensing Licensing 98

Druggist

DECEMBER 9, 2020

Lotions: contain the least amount of oils and higher amounts of water with non-greasy consistency. Topical steroids are not directly classified as anti-itch medicines; however, it is thought that reduced skin itchiness comes from controlling skin inflammation (ibid). Clobetasone has a narrow licensed use. Daktacort cream.

Pharmacy 97

Pharmacy Containment Sales Production 97

Pfizer

FEBRUARY 16, 2023

GCP is the international ethical and scientific quality standard for clinical trials that all clinical researchers need to follow. The companies intend to work with regulatory authorities, and as previously announced, 1,2 aim for Pfizer to potentially submit a Biologics License Application (BLA) to the U.S.

Clinical Trials 76

Clinical Trials Clinical Trials Vaccination Vaccine 76

Pfizer

JANUARY 27, 2023

Pfizer Responds to Research Claims carterda Fri, 01/27/2023 - 19:48 Pfizer Responds to Research Claims Friday, January 27, 2023 - 08:00pm Share New York, N.Y., In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research.

Research 112

Research Vaccination Vaccine Drugs 112

Drug Discovery World

JULY 20, 2023

The Drug Repurposing symposium at WCP 2023 was chaired by Oscar Della Pasqua, Chair Clinical Pharmacology & Therapeutics, University College London, London, UK, and Dr Viviana Giannuzzi, Head of Research Department, Fondazione per la Ricerca, Farmacologica, Gianni Benzi Onlus, Italy.

Drugs 40

Drugs Clinical Trials Clinical Trials Trials 40

Drug Discovery World

MARCH 29, 2023

An example of the current disparity, drawn from data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), can be seen in Romania, Poland or Bulgaria, where a recently approved medicine will take more than 800 days on average before it becomes publicly available compared with Germany, where that figure is 133 days 3.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

The Pharma Data

DECEMBER 19, 2020

Moderna will continue to gather additional data and plans to file a Biologics License Application (BLA) with the FDA requesting full licensure in 2021. On July 28, results from a non-human primate preclinical viral challenge study evaluating the vaccine were published in The New England Journal of Medicine. 75A50120C00034.

Vaccination 52

Vaccination Vaccine Licensing Licensing 52

XTalks

APRIL 24, 2023

According to Dr. Melanie Blank, clinical team leader for General Medicine Branch 1 at the US Food and Drug Administration’s (FDA) Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), the agency is seeing one or two new applications coming in every week for new gene therapies for different diseases.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

The Pharma Data

JANUARY 4, 2021

The program was licensed to Allergan in April 2016 , and Allergan was acquired by AbbVie in May 2020. ” About the License Agreement. Effective 4 January 2021 , the License Agreement is terminated. TOKYO and CAMBRIDGE, England , Jan.

Licensing 40

Licensing Licensing Development Production 40

Pfizer

JANUARY 27, 2023

One carton contains five blister packs of PAXLOVID, as co-packaged nirmatrelvir tablets with ritonavir tablets, providing all required doses for a full five-day treatment course. Disclosure Notice The information contained in this statement is as of January 27, 2023.

Marketing 75

Marketing Production Drugs Licensing 75

Client Pharma

APRIL 3, 2020

Response : contain, control or minimize the impacts of any incident(s). Preparedness : take steps before an incident to ensure effective response and recovery. Recovery : take steps to minimize disruption and recovery times. Q: How are Client-Pharma’s warehousing and distribution channels being managed?

Licensing 40

Licensing Licensing Containment Clinical Research 40

The Pharma Data

MARCH 4, 2021

Discovered at Takeda’s Shonan, Japan research center, soticlestat is a potent, highly selective, first-in-class inhibitor of the enzyme cholesterol 24-hydroxylase (CH24H). President of Research and Development at Takeda. Under the new exclusive agreement, all global rights to soticlestat have been secured by Takeda from Ovid.

Development 52

Development Containment Medicine Clinical Trials 52

The Pharma Data

JANUARY 3, 2021

United Kingdom Medicines and Healthcare Products Regulatory Agency authorized Clinical Trial Application. With these important regulatory clearances for our first-in-human clinical trial for INZ-701 in subjects with ENPP1 deficiency, we have transitioned from a research-stage to a clinical-stage company. BOSTON, Jan.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Containment 52

The Pharma Data

MAY 2, 2022

Under the terms of the settlement agreement, the litigation between the parties in the United States District Court for the District of New Jersey will be ended, and Lupin will have a license to sell its generic product beginning April 2033, or earlier under certain circumstances. About Teva. Teva Pharmaceutical Industries Ltd.

Production 52

Production Containment Medicine FDA Approval 52

Pfizer

JULY 19, 2022

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 is immunocompromised or are on a medicine that affects the immune system. The information contained in this release is as of July 19, 2022.

Vaccination 100

Vaccination Vaccine Medicine Clinical Trials 100

The Pharma Data

JANUARY 24, 2021

Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Food and Drug Administration (“FDA”) approval. PharmaDrug Inc.

Drugs 52

Drugs Containment Development Sales 52

The Pharma Data

APRIL 18, 2022

Novavax licensed and transferred its manufacturing technologies to enable Takeda to develop and manufacture the vaccine at its facility in Hikari. Hyperimmune globulin : Takeda co-founded the CoVIg-19 Plasma Alliance and joined forces with other leading plasma companies to evaluate a hyperimmune globulin medicine in a global clinical trial.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

APRIL 27, 2021

(the Pfizer-BioNTech COVID-19 vaccine) has been granted conditional marketing authorisation by the European Medicines Agency to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. Interactions with other medicinal products or concomitant administration of COMIRNATY® with other vaccines has not been studied.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

Pharmacy Checkers

FEBRUARY 7, 2020

Instead, they choose to spend their time “educating” the public about the dangers of prescription drug importation, warning Americans that it’s not safe to buy lower-cost medicines from other countries over the Internet. According to a study by the Institute of Medicine, 1.5 Pharmacists in the U.S. That’s a dated study from 2006.

Pharmacy 74

Pharmacy Regulation Drugs Medicine 74

The Pharma Data

NOVEMBER 3, 2020

Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, announced today the U.S. It may also allow for priority or rolling review of a company’s Biologics License Application (BLA). LEXINGTON, Mass., About LogicBio Therapeutics. Forward Looking Statements.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Editing Genome 52

The Pharma Data

JANUARY 13, 2021

14, 2021 /PRNewswire/ — MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced the addition of Robert Barrow , an accomplished pharmaceutical executive, as Chief Development Officer. NEW YORK , Jan. About MindMed. About MindMed.

Clinical Trials 52

Clinical Trials Clinical Trials Development Trials 52

The Pharma Data

DECEMBER 20, 2020

We see great promise in delivering psychedelic-based medicines to treat various diseases and disorders and look forward to unveiling clinical study designs,’’ he continued. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About Transcend Biodynamics LLC.

Drug Delivery 52

Drug Delivery Containment Production Development 52